Created by EDGAR Online, Inc. ACTAVIS, INC.

TABLE1 Form Type: 8-K Period End: Jan 23, 2012 Date Filed: Jan 26, 2012 WATSON PHARMACEUTICALS, INC. (Exact name of registrant as specified in its charter)

Nevada (State or other Jurisdiction of Incorporation)

001-13305 (Commission File Number)

95-3872914 (IRS Employer Identification Number)

Created by EDGAR Online, Inc. ACTAVIS, INC. TABLE2 Form Type: 8-K Period End: Jan 23, 2012 Date Filed: Jan 26, 2012 Exhibit No. Exhibit

2.10 Share Purchase Agreement dated January 24, 2012 by and among Watson Pharmaceuticals, Inc., Strides Pharma Limited, I-Investments Pty Ltd, Strides Arcolab Limited, Ascent Pharmahealth Limited and Dennis Bastas. The registrant has omitted from Exhibit 2.1 schedules and exhibits pursuant to Item 601(b)(2) of Regulation S-K, and agrees to furnish supplementally a copy of any omitted schedule or exhibit to the Securities and Exchange Commission upon request.

Created by EDGAR Online, Inc. ACTAVIS, INC. TABLE3 Form Type: 8-K Period End: Jan 23, 2012 Date Filed: Jan 26, 2012 Exhibit No. Description

2.10 Share Purchase Agreement dated January 24, 2012 by and among Watson Pharmaceuticals, Inc., Strides Pharma Limited, I-Investments Pty Ltd, Strides Arcolab Limited, Ascent Pharmahealth Limited and Dennis Bastas. The registrant has omitted from Exhibit 2.1 schedules and exhibits pursuant to Item 601(b)(2) of Regulation S-K, and agrees to furnish supplementally a copy of any omitted schedule or exhibit to the Securities and Exchange Commission upon request.

Created by EDGAR Online, Inc. ACTAVIS, INC. TABLE4 Form Type: 8-K Period End: Jan 23, 2012 Date Filed: Jan 26, 2012 1.00 1.10 1.20 1.30 2.00 2.10 2.20 2.30 2.40 2.50 3.00 3.10 3.20 3.30 3.40 3.50 4.00 4.10 4.20 4.30 4.40 4.50 4.60 4.70 5.00 5.10 5.20 5.30

6.00 7.00 7.10 7.20 7.30 7.40 7.50 7.60

8.00 8.10 8.20 8.30

eated by EDGAR Online, Inc.

TAVIS, INC. BLE4 rm Type: 8-K riod End: Jan 23, 2012 te Filed: Jan 26, 2012 Definitions and interpretation Definitions Interpretation Several liability Agreement to buy and sell Shares Sale and purchase Date for Completion Encumbrances and rights Title and risk Waiver of pre-emptive rights Purchase Price and Completion Payment Purchase Price Manner of payment of Purchase Price Payments affecting the Purchase Price Payment of the Completion Payment Consent Contracts Completion Time and place for Completion Sellers' obligations at Completion Buyer's obligations at Completion Group's obligations at Completion Delayed delivery of Completion items Simultaneous actions No right to terminate or rescind Completion Accounts Preparation Purchase Price adjustments following Completion Accounts Payment of Working Capital Adjustment Amount and Net Financial Debt Adjustment Amount Access to Records after Completion Tax matters Completion of Tax returns and calculations Tax enquiries or audits by Government Agency Tax Indemnity Tax effect of Claims Due date for payments under clause 7.3 Deferral of due date for payments under clause 7.3

Sellers' Warranties Warranties Disclosure Material Separate warranties

6 6 19 20 20 20 20 20 21 21 21 21 21 21 21 22 22 22 22 25 26 26 26 26 27 27 27 27 28 28 28 30 32 32 32 33

33 33 33 34

Created by EDGAR Online, Inc. ACTAVIS, INC. TABLE5 Form Type: 8-K Period End: Jan 23, 2012 Date Filed: Jan 26, 2012 -----------------------------------------------------------------------------------------------------------------------------------------8.40 Indemnity for breach of Warranty 8.50 Qualification as to knowledge 8.60 Buyer's acknowledgments 9.00 9.10 9.20 9.30 9.40 9.50 9.60 9.70 9.80 9.90 9.10 9.11 9.12 Claiming under the Sellers' Warranties Notice of Warranty Claims Warrantors to consider Warranty Claims Limits on types of Warranty Claims Limitations in relation to Tax Time limits for Warranty Claims Maximum and minimum amounts Circumstances where limitations do not apply Buyer's obligations for Warranty Claims relating to Third Parties Buyer must pursue Third Party Benefits received Mitigation Other actions

10.00 Buyer's Warranties 11.00 SPL Guarantor Warranties 12.00 12.10 12.20 12.30 13.00 13.10 13.20 13.30 13.40 Release of Guarantees Parties to procure - Sellers' Guarantees Buyer's obligations Parties to procure - Subsidiary Guarantees Assistance in relation to change of control and lease assignments Consent to assignment Consent of other persons Where consents not obtained Third party costs

14.00 Interest on overdue payments 14.10 Payment of default interest 14.20 Other rights not affected 15.00 Public announcements 15.10 Making announcements 15.20 Requirements 16.00 Confidentiality 16.10 Obligations of confidentiality

16.20 16.30 16.40 16.50 16.60

Exceptions Authorised disclosure Return or destruction of Confidential Information Liability for breach by Recipient Post Completion

17.00 Restrictive covenant 17.10 Restrictions 17.20 Restraint Period

34 34 34 35 35 35 35 37 38 38 39 39 41 41 41 41 41 42 43 43 43 44 44 44 44 45 45 45 45 45 45 45 46 46 46

46 47 47 48 48 48 48 48

Created by EDGAR Online, Inc. ACTAVIS, INC. TABLE6 Form Type: 8-K Period End: Jan 23, 2012 Date Filed: Jan 26, 2012 -----------------------------------------------------------------------------------------------------------------------------------17.30 Restraint Area 49 17.40 Permitted involvement 49 17.50 Independence of restrictions 50 17.60 Reasonableness of restraint 50 18.00 18.10 18.20 18.30 18.40 Dispute resolution Delivering a dispute notice Parties must negotiate Resolution by managing directors Other proceedings 50 50 50 51 51 51 51 51 52 52 52 52 52 52 53 53 53 53 53 53 54 54 54 54 54 54 54 54 55 55 55 55 55 55

19.00 Party as trustee 19.10 Capacity 19.20 Trustee's warranties 20.00 20.10 20.20 20.30 20.40 20.50 20.60 21.00 21.10 21.20 21.30 21.40 22.00 22.10 22.20 22.30 22.40 22.50 22.60 22.70 22.80 22.90 22.10 22.11 22.12 22.13 Guarantee and indemnity Limitations Guarantee Indemnity Continuing obligation Obligations and rights not affected by certain matters Reinstating rights GST Definitions Consideration is GST exclusive Payment of GST Reimbursement of expenses General Nature of obligations Time of the essence Entire understanding Survival of obligations No adverse construction Further assurances Waiver Severability Successors and assigns No assignment Consents and approvals No variation Costs

22.14 22.15 22.16 22.17 22.18 22.19 22.20 22.21

Duty Governing law and arbitration Notices Counterparts Conflicting provisions Non merger Operation of indemnities No right of set-off

55 56 56 58 58 58 58 58

Created by EDGAR Online, Inc. ACTAVIS, INC. TABLE7 Form Type: 8-K Period End: Jan 23, 2012 Date Filed: Jan 26, 2012 ---------------------------------------------------------------------------------------------------------------22.22 Relationship of parties 58 22.23 Benefits held on trust 58 22.24 Indemnity for Deed of Cross Guarantee 59 22.25 Pharmacy loans 59 22.26 Excluded Business 59 22.27 Related Party Loans 70 22.28 Executive Option Plans 60

Schedule 1 - Share Details Schedule 3 - Bank Debt Schedule 4 - The Sellers' Warranties Schedule 5 - The Disclosure Letter Schedule 6 - Real Property Interests Schedule 7 - Equipment Leases Schedule 8 - Intellectual Property Schedule 9 - Key Contracts Schedule 10 - Data Room index Schedule 11 - Completion Accounts Schedule 12 - Consent Contracts Schedule 13 - Executive Option Plans Schedule 14 - Sellers' Guarantees Schedule 15 - Funds flow for Completion Payment Annexure 1 - Plant and Equipment Annexure 2 - Accounts

58 66 68 85 86 89 90 91 93 94 100 104 105 106 110 111

Annexure 3 - Management Accounts Annexure 4 - Opinion Letters Annexure 5 - Closing Financing Documents

112 113 114

Created by EDGAR Online, Inc. ACTAVIS, INC. TABLE8 Form Type: 8-K Period End: Jan 23, 2012 Date Filed: Jan 26, 2012 Bank: St George Bank Level 8, 530 Collins Street Melbourne VIC 3000 Australia 333 030 700221584 Middletons - Trust Account 10044459 SGBLAU2S;

BSB: Account No: Account Name: Reference: Swift Code:

Created by EDGAR Online, Inc. ACTAVIS, INC. TABLE9 Form Type: 8-K Period End: Jan 23, 2012 Date Filed: Jan 26, 2012 Address: Attention: Facsimile: Email: Level 14, 440 Collins Street, Melbourne, Victoria, Australia Dennis Bastas +61 3 8677 6666 Dennis@Bastas.com

Created by EDGAR Online, Inc. ACTAVIS, INC. TABLE10 Form Type: 8-K Period End: Jan 23, 2012 Date Filed: Jan 26, 2012 Address: Attention: Facsimile: Email: Strides House, Bilehahalli, Bannerghatta Road, Bangalore 560076, India Manish Gupta (CFO) +91 96865 92005 manish.gupta@stridesarco.com

Created by EDGAR Online, Inc. ACTAVIS, INC. TABLE11 Form Type: 8-K Period End: Jan 23, 2012 Date Filed: Jan 26, 2012 Address: Attention: Facsimile: Email: Exchange House, Primrose Street, London EC2A 2HS, United Kingdom Alan Montgomery and Marc Perkins +44 20 7374 0888 alan.montgomery@herbertsmith.com and marc.perkins@herbertsmith.com

Created by EDGAR Online, Inc. ACTAVIS, INC. TABLE12 Form Type: 8-K Period End: Jan 23, 2012 Date Filed: Jan 26, 2012 Address: Attention: Email: Morris Corporate Centre III, 400 Interpace Parkway, Parsippany, New Jersey, USA 07054 Vice President -Corporate Business Development Sig.Kirk@watson.com

Created by EDGAR Online, Inc. ACTAVIS, INC. TABLE13 Form Type: 8-K Period End: Jan 23, 2012 Date Filed: Jan 26, 2012 Address: Attention: Email: Morris Corporate Centre III, 400 Interpace Parkway, Parsippany, New Jersey, USA 07054 General Counsel David.Buchen@watson.com

Created by EDGAR Online, Inc. ACTAVIS, INC. TABLE14 Form Type: 8-K Period End: Jan 23, 2012 Date Filed: Jan 26, 2012 ----------------------------------------------------------------------------------------------------------------------------------------Executed by Ascent Pharmahealth ) Limited ACN 107 340 367 in accordance ) with section 127(1) of the ) Corporations Act 2001 (Cth): ) /s/ Dennis Bastas Signature of director /s/ Andrew Burgess Signature of director or company secretary* *delete whichever does not apply Andrew Burgess Name (please print)

Dennis Bastas Name (please print) Executed by Watson Pharmaceuticals ) Inc., a company registered in Nevada ) in the United States of America under ) commission file number 001-13305 ) /s/ David Buchen Signature of attorney David Buchen Name (please print) Executed by Dennis Bastas )

/s/ R. T. Joyce Witness R. T. Joyce Name (please print)

) ) ) /s/ Dennis Bastas Signature Dennis Bastas Name (please print) /s/ Andrew Burgess Witness Andrew Burgess Name (please print)